Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $178.84 million. The enterprise value is -$76.89 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRBU has 90.55 million shares outstanding. The number of shares has increased by 34.02% in one year.
| Current Share Class | 90.55M |
| Shares Outstanding | 90.55M |
| Shares Change (YoY) | +34.02% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 59.26% |
| Float | 81.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.32 |
| Forward PS | 10.45 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.09.
| Current Ratio | 7.38 |
| Quick Ratio | 7.18 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.60% and return on invested capital (ROIC) is -27.48%.
| Return on Equity (ROE) | -43.60% |
| Return on Assets (ROA) | -25.14% |
| Return on Capital (ROIC) | -27.48% |
| Revenue Per Employee | $72,627 |
| Profits Per Employee | -$937,468 |
| Employee Count | 158 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRBU has paid $193,000 in taxes.
| Income Tax | 193,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.45% in the last 52 weeks. The beta is 2.26, so CRBU's price volatility has been higher than the market average.
| Beta (5Y) | 2.26 |
| 52-Week Price Change | -62.45% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 3.21 |
| Relative Strength Index (RSI) | 42.58 |
| Average Volume (20 Days) | 1,905,453 |
Short Selling Information
The latest short interest is 9.94 million, so 10.98% of the outstanding shares have been sold short.
| Short Interest | 9.94M |
| Short Previous Month | 11.51M |
| Short % of Shares Out | 10.98% |
| Short % of Float | 12.18% |
| Short Ratio (days to cover) | 11.03 |
Income Statement
In the last 12 months, CRBU had revenue of $11.48 million and -$148.12 million in losses. Loss per share was -$1.65.
| Revenue | 11.48M |
| Gross Profit | -119.49M |
| Operating Income | -161.28M |
| Pretax Income | -123.25M |
| Net Income | -148.12M |
| EBITDA | -157.80M |
| EBIT | -161.28M |
| Loss Per Share | -$1.65 |
Full Income StatementBalance Sheet
The company has $228.18 million in cash and $26.64 million in debt, giving a net cash position of $254.37 million or $2.81 per share.
| Cash & Cash Equivalents | 228.18M |
| Total Debt | 26.64M |
| Net Cash | 254.37M |
| Net Cash Per Share | $2.81 |
| Equity (Book Value) | 281.20M |
| Book Value Per Share | 3.11 |
| Working Capital | 205.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$124.11 million and capital expenditures -$6.64 million, giving a free cash flow of -$130.75 million.
| Operating Cash Flow | -124.11M |
| Capital Expenditures | -6.64M |
| Free Cash Flow | -130.75M |
| FCF Per Share | -$1.44 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,405.52% |
| Pretax Margin | -1,289.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -395.48% |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.02% |
| Shareholder Yield | -34.02% |
| Earnings Yield | -83.46% |
| FCF Yield | -73.67% |
Analyst Forecast
The average price target for CRBU is $14.00, which is 608.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 608.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 61.96% |
| EPS Growth Forecast (5Y) | -11.65% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of 0.97 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.97 |
| Piotroski F-Score | 1 |